Taking a leaf from the book of oral tolerance

Slides:

Advertisements

Similar presentations

An evolutionarily conserved program of B-cell development and activation in zebrafish by Dawne M. Page, Valerie Wittamer, Julien Y. Bertrand, Kanako L.

Advertisements

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin by Bin Zhang, Chunlei Zheng, Min Zhu, Jiayi Tao, Matthew.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma by Joshua Richter, Natalia Neparidze,

Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes.

An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity by Francesca S. Gazzaniga,

Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry by Po-Lin Chiu, George M. Bou-Assaf,

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene by Xiaoou Zhou,

Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment by Troy D. Randall, and Irving.

by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and

MBL: mostly benign lymphocytes, but…

Hydroxyurea makes inflammation “just right”?

TCR-MHC-peptide(s): in vivo veritas

“Vitamin hypothesis”: explanation for allergy increase?

Triple play of H pylori in ITP

Bulging glands? Blame it on B cells

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study by Lori-Ann Linkins,

by Timothy P. Hughes, and David M. Ross

Defects in DBA: more than meets the eye

Finding a diamond in the (mouse is) rough

Next-generation leukemia immunotherapy

Another Notch on the belt

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

by Zhenping Zhu Blood Volume 108(6): September 15, 2006

Transplants for the elderly in myeloma

How I treat elderly patients with myeloma

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

Nonmyeloablative conditioning for relapsed follicular lymphoma

Antibody-modified T cells: CARs take the front seat for hematologic malignancies by Marcela V. Maus, Stephan A. Grupp, David L. Porter, and Carl H. June.

FNAIT: the fetus pleads guilty!

Leukemia initiated by PMLRARα: the PML domain plays a critical role while retinoic acid–mediated transactivation is dispensable by Scott C. Kogan, Suk-hyun.

T regulatory cells turn on T regulatory cells

Gnawing at Metchnikoff’s paradigm

פחת ורווח הון סוגיות מיוחדות תהילה ששון עו"ד (רו"ח) ספטמבר 2015

Genetic sequence analysis of inherited bleeding diseases

Engineering regulatory T cells against factor VIII inhibitors

Fluorescent neutrophils throw the spotlight on inflammation

Deep mining of the RBC proteome

Acute promyelocytic leukemia, microgranular variant

Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,

by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T

Suppression, surprise: galectin-10 and Treg cells

by Julia E. Geddings, and Nigel Mackman

How we choose factor VIII to treat hemophilia

An actuarial GPS for hemophilic longevity

Has the T cell bitten off more than it can chew?

by Sabah Sallah, and Jim Y. Wan

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Stage C or not stage C…? by Claire Dearden Blood

ROCK and Rho(ll) in bone marrow

Latest lymphoma classification is skin deep

HU for acute treatment of sickle VOC?

Transplantation of Umbilical Cord Blood–Derived Cells for Novel Indications in Regenerative Therapy or Immune Modulation: A Scoping Review of Clinical.

Activity of eltrombopag in severe aplastic anemia

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Expression of pathogenesis-related (PR) genes in transgenic barley in response to pathogen inoculation. Expression of pathogenesis-related (PR) genes in.

by Kalpana Parvathaneni, and David W. Scott

Cell-Based Therapy Using Umbilical Cord Blood for Novel Indications in Regenerative Therapy and Immune Modulation: An Updated Systematic Scoping Review.

Pauline Damien, David S. Allan

The von Willebrand Factor protein showing various functional domains that have been mapped to regions of the cDNA. The von Willebrand Factor protein showing.

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

How I treat Burkitt lymphoma in adults

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.

by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio

Initial treatment of CLL: integrating biology and functional status

by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal

SEPTEMBER 2019 ISSUE/42 nd VOLUME.

Presentation transcript:

Taking a leaf from the book of oral tolerance by David W. Scott Blood Volume 124(10):1548-1549 September 4, 2014 ©2014 by American Society of Hematology

Proposed clinical application: FVIII domains expressed in transgenic plants can be ingested and processed by the mucosal immune system to induce tolerance to FVIII. Proposed clinical application: FVIII domains expressed in transgenic plants can be ingested and processed by the mucosal immune system to induce tolerance to FVIII. David W. Scott Blood 2014;124:1548-1549 ©2014 by American Society of Hematology